FDA approves 'glowing tumor' drug to help surgeons identify ovarian cancer cells

November 30, 2021

FDA approves 'glowing tumor' drug to help surgeons identify ovarian cancer cells
By Amy McGorry

Cytalux (pafolacianince), a drug that binds to ovarian cancer tissue and glows when exposed to fluorescent light, has been approved by the U.S. Food and Drug Administration (FDA) to help surgeons detect ovarian tumors during surgical procedures in patients.